@entity101 and XXXX in bone marrow transplant recipients.

@entity1 @entity644 @entity8 @entity101 @entity1272 @entity786 @entity177 @entity205 @entity810 @entity1985 @entity4028 @entity1760
The incidence of @entity810 , @entity101 and electrolyte disorders in 64 bone marrow transplant recipients randomized to receive either @entity205 or @entity786 was investigated. Sixty-four per cent of @entity1 developed @entity810 , 75 per cent @entity101 , and 88 per cent significant @entity1272 . The incidence of diastolic @entity101 and @entity1272 was greater in the patents treated with @entity205 . @entity1272 was due to @entity1760 wasting by the kidney. Both groups received similar cumulative doses of @entity4028 antibiotics. Significant @entity644 developed in all but one @entity1 and @entity1985 -range @entity644 was noted in 21 per cent. The cause of the @entity644 is unclear; no obvious morphologic changes were seen at autopsy in @entity1 who exhibited @entity1985 -range @entity644 . The @entity8 were shown to be transient in @entity1 who were observed for periods ranging from one to three years. It is concluded that @entity101 , @entity177 and @entity1272 are common in the setting of bone marrow transplantation. Whereas @entity205 probably aggravates the severity of these disorders, it is likely that other factors (e.g., @entity4028 antibiotics) play a major role as shown by the high incidence of renal and electrolyte disorders in @entity1 treated with @entity786 alone.
